Latest Surgical oncology Stories
LONDON, June 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
ProMark(TM) has Potential to Transform Prostate Cancer Care by Aiding Doctors and Patients with Appropriate Treatment Assessment CAMBRIDGE, Mass., June 2, 2014 /PRNewswire/ -- Today,
The Firm is evaluating hysterectomy cancer lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma or other cancers due to power morcellation in gynecological surgery.
Wisconsin researchers find many more peritoneal mesothelioma patients could survive if they were treated with surgery. Raleigh, NC (PRWEB) May 29, 2014
Federal regulators recently warned that power morcellators should not be used during minimally invasive gynecological procedures, including hysterectomy or myomectomy, over the potential for these
The Firm is investigating morcellator lawsuits on behalf of women who allegedly suffered the spread of uterine cancer due to power morcellation. New York, New
Ashley Brittain Landers of Schlichter, Bogard & Denton, LLP reports that the FDA has issued proposed orders to reclassify transvaginal mesh devices to the classification of high-risk.
Last month, the U.S.
The Firm is investigating power morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma or other cancers due to use of morcellation in laparoscopic hysterectomy
A new study has found that approximately 70 percent of women who have both breasts removed after having a breast cancer diagnosis in a single breast do it regardless of having a low risk of having cancer in the healthy breast.